State Street Drops After Q4 Results: Beat on Paper, But Costs Raise Questions
State Street shares slipped after the bank posted a Q4 earnings and revenue beat, but investors focused on restructuring costs and a higher-than-expected expense outlook for 2026.
Telegram News Wire
BSX Shares Dip as Boston Scientific Unveils Biggest Deal in 20 Years
Boston Scientific stock slipped 3.6% in premarket trading after the company announced a $14.5 billion deal to buy Penumbra.